CLINICAL_TRIALS
trial_result
· 2020-02-06
Clinical Trial Update: A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis [Phase 2]
Summary
Phase 2 study of ATI-502 topical solution for atopic dermatitis completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-06